Paolo Tombesi, EVP & Chief Financial Officer at Turning Point Therapeutics, Inc. (TPTX), sold 2,366 shares at $74.94 ($177K) on 2022-07-27, disclosed to the SEC on 2022-07-29.
Open-market sale of $177k TPTX by EVP & Chief Financial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $74.94 | 1,183 | $89K | 50.0% |
| 2 | $74.94 | 1,183 | $89K | 50.0% |
| Total | $74.94 avg | 2,366 | $177K | 100% |
| Filing → |
| EPZM | SELL | 2020-03-26 | $19K | — | Filing → |